OpenAlex
PricingAboutJobs
Log inGet started
Work

Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia

HTML

Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: European Heart Journal
DOI: 10.1093/eurheartj/ehm328
Authors: D. J. van Veldhuisen, K. Dickstein, A. Cohen-Solal, D. J.A. Lok, S. M. Wasserman, N. Baker, D. Rosser, J. G.F. Cleland, P. Ponikowski
Institutions: University Medical Center Groningen, University of Groningen, Stavanger University Hospital, Hôpital Beaujon, Deventer Ziekenhuis, Amgen (United States), Amgen (United Kingdom), University of Hull, Castle Hill Hospital
Language: English

Topic: Erythropoietin and Anemia Treatment
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: darbepoetin alfa, chronic heart failure, anemia, erythropoiesis-stimulating agents, dosing regimen, weight-based dosing, fixed dose, hemoglobin response, 6-minute walk distance, NYHA functional class, Kansas City Cardiomyopathy Questionnaire, quality of life, left ventricular ejection fraction, patient safety, adverse events
SDG: Good health and well-being

Open Access status: closed

Funder: Amgen
OpenAlex ID: W2164945887
FWCI: 20.9
Cites: 26
Cited by: 202
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms